Corium International

Corium International is owned by Gurnet Point Capital.

They are in:

• Pharmaceuticals67%
• Fund33%

View the org chart displaying its 11 main executives

Most searched biographies at Corium International

• Perry Sternberg, Director, President and Chief Executive Officer
• Travis Wilson, Director
• Sophie Kornowski, Chairman of the Board

Create your alert
to follow the executive moves at Corium International.

Gurnet Point Capital has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Corium International

• News & Media – Corium Inc.
• http://www.coriumintl.com/wp-content/uploads/2019/07/CORI_NEWS_2018_10_11_General_Releases.pdf
• https://www.coriumintl.com/wp-content/uploads/2018/11/Corium-Gurnet-Press-Release-Closing-FINAL.pdf
• http://www.coriumintl.com/wp-content/uploads/2018/11/Corium-Gurnet-Press-Release-Closing-FINAL.pdf

Social media about Corium International

• Corium International on Wikipedia, Google News & Yahoo Finance
• Corium International on LinkedIn, Twitter & YouTube

Contact by email its executives including Perry Sternberg

Call Corium International at +1 650...

View the org chart

Register to receive your alert

Report an error